What is behind programmatic treatment outcome definitions for tuberculosis?

Eur Respir J. 2020 Jul 23;56(1):2001751. doi: 10.1183/13993003.01751-2020. Print 2020 Jul.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Treatment Outcome
  • Tuberculosis* / diagnosis
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents